Healthware Group has released the expert opinion report, ‘Digital therapeutics to enhance the care pathways for depression across the national health service: expert propo
As we close in on Frontiers Health 2022, pharmaphorum is chatting with members of the Steering Committee to give you a sneak peek of what to expect in Milan. Interested in signing up?
As Frontiers Health approaches, we’re featuring interviews with members of the steering committee to give you a sneak peek of what to expect in Milan. Interested in signing up?
Health innovation and technology specialist Healthware Group has added another element to its business with the launch of a dedicated medical communications and education division.
GSK's severe asthma therapy Nucala could find a new lease of life as a treatment for chronic obstructive pulmonary disease (COPD) after showing a clear benefit in a phase 3 trial.<